Literature DB >> 17524099

Planning for pandemic influenza: effect of a pandemic on the supply and demand for blood products in the United States.

Ann B Zimrin1, John R Hess.   

Abstract

BACKGROUND: Influenza causes episodic pandemics when viral antigens shift in ways that elude herd immunity. Avian influenza A H5N1, currently epizootic in bird populations in Asia and Europe, appears to have pandemic potential. STUDY DESIGN AND METHODS: The virology of influenza, the history of the 1918 pandemic, and the structure of the health care and the blood transfusion systems are briefly reviewed. Morbidity and mortality experience from the 1918 pandemic are projected onto the current health care structure to predict points of failure that are likely in a modern pandemic.
RESULTS: Blood donor centers are likely to experience loss of donors, workers, and reliable transport of specimens to national testing laboratories and degradation of response times from national testing labs. Transfusion services are likely to experience critical losses of workers and of reagent red cells (RBCs) that will make their automated procedures unworkable. Loss of medical directors, supervisors, and lead technicians may make alternative procedures unworkable as well.
CONCLUSIONS: Lower blood collection capacity and transfusion service support capability will reduce the availability of RBCs and especially of platelets. Plans for rationing medical care need to take the vulnerability of the blood transfusion system into account.

Entities:  

Mesh:

Year:  2007        PMID: 17524099     DOI: 10.1111/j.1537-2995.2007.01225.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

Review 1.  Concise review: production of cultured red blood cells from stem cells.

Authors:  Eric E Bouhassira
Journal:  Stem Cells Transl Med       Date:  2012-11-26       Impact factor: 6.940

2.  Institutional futility policies are inherently unfair.

Authors:  Philip M Rosoff
Journal:  HEC Forum       Date:  2013-09

3.  Beliefs underlying blood donors' intentions to donate during two phases of an avian influenza outbreak.

Authors:  Barbara M Masser; Katherine M White; Kyra Hamilton; Blake M McKimmie
Journal:  Transfus Apher Sci       Date:  2011-12-03       Impact factor: 1.764

4.  Obstetric protocols in the setting of a pandemic.

Authors:  Rupsa C Boelig; Calvin Lambert; Juan A Pena; Joanne Stone; Peter S Bernstein; Vincenzo Berghella
Journal:  Semin Perinatol       Date:  2020-07-24       Impact factor: 3.300

5.  Impact of COVID-19 on Blood Donation and Supply: A Multicenter Cross-Sectional Study from Saudi Arabia.

Authors:  Nora Y Hakami; Afnan J Al-Sulami; Wafaa A Alhazmi; Talal H Qadah; Waleed M Bawazir; Abdullah Y Hamadi; Amani Y Owaidah; Razan A Alhefzi; Fawaz Y Hamdi; Amr Maqnas; Ghassab F Alghassab; Maha A Badawi; Salwa I Hindawi
Journal:  Biomed Res Int       Date:  2022-01-12       Impact factor: 3.411

6.  Vox Sanguinis International Forum on transfusion services' response to COVID-19: Summary.

Authors:  Mark H Yazer; Bryon Jackson; Monica Pagano; Naomi Rahimi-Levene; Victoria Peer; José Luis Bueno; Ryan P Jackson; Hua Shan; Luiz Amorim-Filho; Maria-Esther Lopes; Carla Boquimpani; Ulrik Sprogøe; Mie Topholm Bruun; Kjell Titlestad; Kylie Rushford; Erica M Wood; Zoe K McQuilten; Vincenzo de Angelis; Michela Delle Donne; Mike Murphy; Julie Staves; Duck Cho; Fumihiko Nakamura; Akira Hangaishi; Jeannie Callum; Yulia Lin; Mostafa Mogaddam; Ahmad Gharehbaghian; Miquel Lozano
Journal:  Vox Sang       Date:  2020-08       Impact factor: 2.996

7.  Triage tool for the rationing of blood for massively bleeding patients during a severe national blood shortage: guidance from the National Blood Transfusion Committee.

Authors:  Heidi Doughty; Laura Green; Jeannie Callum; Michael F Murphy
Journal:  Br J Haematol       Date:  2020-05-20       Impact factor: 8.615

8.  In Vitro Generation of Red Blood Cells from Stem Cell and Targeted Therapy.

Authors:  Ping Zhou; Mouna Ouchari; Yun Xue; Qinan Yin
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.